Market capitalization | $21.40b |
Enterprise Value | $24.59b |
PER (TTM) P/E ratio | 56.84 |
EV/FCF (TTM) EV/FCF | 40.11 |
EV/Sales (TTM) EV/Sales | 4.52 |
P/S ratio (TTM) P/S ratio | 3.93 |
P/B ratio (TTM) P/B ratio | 3.40 |
Dividend yield | 0.94% |
Last dividend (FY24) | $2.03 |
As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.
9 Analysts have issued a Steris forecast:
9 Analysts have issued a Steris forecast:
Mar '24 |
+/-
%
|
||
Turnover | 5,442 5,442 |
10%
10%
|
|
Gross income | 2,351 2,351 |
9%
9%
|
|
EBITDA | 1,423 1,423 |
7%
7%
|
EBIT (operating result) EBIT | 858 858 |
10%
10%
|
Net profit | 378 378 |
253%
253%
|
Figures in millions USD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.
Head office | Ireland |
CEO | Daniel Carestio |
Employees | 18,179 |
Founded | 2016 |
Website | www.steris.com |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.